Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status

por Brusa, Stefano, Terracciano, Daniela, Bruzzese, Dario, Fiorenza, Mariano, Stanziola, Lucia, Pinchera, Biagio, Valente, Valeria, Gentile, Ivan, Cittadini, Antonio, Mormile, Ilaria, Mormile, Mauro, Portella, Giuseppe
Publicado 2022

Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study

por Capasso, Nicola, Palladino, Raffaele, Cerbone, Vincenza, Spiezia, Antonio Luca, Covelli, Bianca, Fiore, Antonia, Lanzillo, Roberta, Carotenuto, Antonio, Petracca, Maria, Stanziola, Lucia, Scalia, Giulia, Brescia Morra, Vincenzo, Moccia, Marcello
Publicado 2022